Covered recipient · General Payments record
MARK PACKER
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2025
$3,460,192.91
- Reported across 206 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $424,487.50 | 22 |
| Food and Beverage | $855.38 | 3 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| LENSAR, Inc. | $232,480.38 | 16 |
| Beaver-Visitec International, Inc. | $127,125.00 | 1 |
| Bausch & Lomb Americas Inc. | $37,612.50 | 1 |
| Tarsus Pharmaceuticals, Inc. | $28,125.00 | 7 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (25)
Sorted by paying entity, then date · as published by CMS
Program year 2025 201920202021202220232024
Record-level detail is published for PY2025; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Bausch & Lomb Americas Inc. | $37,612.50 | 05/27/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1254838506 | CMS |
| Beaver-Visitec International, Inc. | $127,125.00 | 11/28/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1251337650 | CMS |
| LENSAR, Inc. | $10,375.00 | 01/03/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336844 | CMS |
| LENSAR, Inc. | $19,000.00 | 01/16/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336840 | CMS |
| LENSAR, Inc. | $9,000.00 | 02/05/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336846 | CMS |
| LENSAR, Inc. | $13,250.00 | 03/07/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336842 | CMS |
| LENSAR, Inc. | $20,000.00 | 04/04/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336824 | CMS |
| LENSAR, Inc. | $155.97 | 04/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249335934 | CMS |
| LENSAR, Inc. | $541.18 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249336004 | CMS |
| LENSAR, Inc. | $158.23 | 04/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1249336650 | CMS |
| LENSAR, Inc. | $20,000.00 | 05/06/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336828 | CMS |
| LENSAR, Inc. | $20,000.00 | 06/03/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336830 | CMS |
| LENSAR, Inc. | $20,000.00 | 07/02/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336826 | CMS |
| LENSAR, Inc. | $20,000.00 | 08/04/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336834 | CMS |
| LENSAR, Inc. | $20,000.00 | 09/05/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336836 | CMS |
| LENSAR, Inc. | $20,000.00 | 10/06/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336832 | CMS |
| LENSAR, Inc. | $20,000.00 | 11/07/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336838 | CMS |
| LENSAR, Inc. | $20,000.00 | 12/02/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1249336822 | CMS |
| Tarsus Pharmaceuticals, Inc. | $7,500.00 | 05/21/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891395 | CMS |
| Tarsus Pharmaceuticals, Inc. | $2,125.00 | 07/16/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891397 | CMS |
| Tarsus Pharmaceuticals, Inc. | $2,125.00 | 08/26/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891401 | CMS |
| Tarsus Pharmaceuticals, Inc. | $3,625.00 | 09/22/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891403 | CMS |
| Tarsus Pharmaceuticals, Inc. | $3,125.00 | 10/08/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891405 | CMS |
| Tarsus Pharmaceuticals, Inc. | $3,875.00 | 11/12/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891407 | CMS |
| Tarsus Pharmaceuticals, Inc. | $5,750.00 | 12/19/2025 | Consulting Fee | Undisputed | 06/30/2026 | 1233891409 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.